Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer.

MLA

Prabhu, Sathyen A., et al. “Inhibition of the MNK1/2-EIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer.” Molecular Cancer Therapeutics, vol. 22, no. 2, Feb. 2023, pp. 192–204. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-22-0092.

APA

Prabhu, S. A., Moussa, O., Gonçalves, C., LaPierre, J. H., Chou, H., Huang, F., Richard, V. R., Ferruzo, P. Y. M., Guettler, E. M., Soria-Bretones, I., Kirby, L., Gagnon, N., Su, J., Silvester, J., Krisna, S. S., Rose, A. A. N., Sheppard, K. E., Cescon, D. W., Mallette, F. A., … Miller, W. H. (2023). Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer. Molecular Cancer Therapeutics, 22(2), 192–204. https://doi.org/10.1158/1535-7163.MCT-22-0092

Chicago

Prabhu, Sathyen A, Omar Moussa, Christophe Gonçalves, Judith H LaPierre, Hsiang Chou, Fan Huang, Vincent R Richard, et al. 2023. “Inhibition of the MNK1/2-EIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer.” Molecular Cancer Therapeutics 22 (2): 192–204. doi:10.1158/1535-7163.MCT-22-0092.